Owing to the joint efforts of Ministry of Economic Development and Trade of Ukraine, Ministry of Health of Ukraine and the European Business Association Health Care Committee, the Government of Ukraine has adopted necessary amendments to the Resolutions of the Cabinet of Ministers of Ukraine (CMU) on Drug Reference Pricing and Reimbursement.
Now the tension on the pharmaceutical market is alleviated, for the free circulation of drugs for treatment of cardiovascular diseases, diabetes and asthma included into the list of 21 INN and to be reimbursed for the benefits of the Ukrainian citizens, is resumed. Thus, participation in the reimbursement programme is voluntary for market entities while patients are ensured with a free choice when buying necessary drugs as compensated by the state or at their own expense.
We recognize the adoption of the amendments to the CMU Resolutions in favor of the uninterrupted supply of necessary drugs to the citizens of Ukraine.
European Business Association expects that the Register of Reference Prices and that of the Reimbursement Prices will soon be published as acceptable, the Government of Ukraine will ensure that the agreements with pharmacies are concluded and the reimbursement mechanism will be practically implemented starting from 1 April 2017.
We are grateful to the governmental authorities for understanding that the efficiency analysis of the adopted mechanism is obligatory to be performed in order to further improve the implemented mechanism and ensure effective application of state budget funds. The relevant provision is laid down in the adopted amendments to the CMU Resolutions.